Remedy Entertainment

13.30 EUR

-0.75 %

11,408 following
Corporate customer

REMEDY

NASDAQ Helsinki

Software

Technology

-0.75 %
+9.74 %
-8.15 %
-12.50 %
+2.62 %
-24.69 %
-47.12 %
-69.67 %
+98.80 %

Remedy Entertainment is a game developer. Its operations are primarily focused on the development of action games, with a particular focus on 3D technology. Examples of games that the company has developed include several different versions of Alan Wake, Max Payne, and Control. Remedy also develops its own game engine and tooling technology that powers many of its games. The company was founded in 1995 and is headquartered in Espoo, Finland.

Read more
Market cap
181.42M EUR
Turnover
87.02K EUR
P/E (adj.) (26e)
67.88
EV/EBIT (adj.) (26e)
38.91
P/B (26e)
3.07
EV/S (26e)
1.31
Dividend yield-% (26e)
-
Coverage
Recommendation
Buy
Target price
19.00 EUR
Updated
05.05.2026
Disclaimer
Atte Riikola
Atte Riikola

Analyst

Latest research

Latest analysis report

Released: 06.05.2026

Latest extensive report

Released: 18.12.2024

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
11.8
2026

Interim report Q2'26

3.11
2026

Business review Q3'26

Risk
Business risk
Valuation risk
Low
High
ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Forum discussions
JC’s interview
5/5/2026, 12:59 PM
by Henkka
29
The first Control is certainly pulling in impressive numbers. Of course, the price per unit is next to nothing, but this can be seen as marketing for Control 2 (Control Resonant). Wasn’t it announced last year that Control had sold 5 million copies during its lifecycle? And according...
5/5/2026, 1:01 PM
by Spwni
24
Control Resonant featured in the Summer Games Fest (June 5, 2026) promo video. Around the 0:40 mark:
yesterday
23
In my opinion, the market is not taking into account Remedy’s new localization regions for Control Resonant, which are significant additions compared to the previous Control, especially if the game receives good reviews. China alone is a major localization addition, as are Brazil...
5/5/2026, 10:59 AM
by Thiebault
21
Here is the company report from Atte following Q1. We reiterate our Buy recommendation for Remedy and our target price of EUR 19.0. The Q1 figures were clearly better than our expectations, as both development fees and game sales surprised positively. In the big picture, however,...
yesterday
by Sijoittaja-alokas
17
The gaming industry is aware that Western games generally haven’t sold well in Asia. However, there are examples where sales have increased significantly due to localization. Therefore, I think it is realistic to assume that sales will increase by +10-30% compared to a situation ...
5/5/2026, 12:06 PM
by Thiebault
16
The webcast was short and concise. In my opinion, nothing particularly new was presented compared to the morning report. I think JC presented himself quite well. The practical test for JC will be how Resonant performs outside the traditional EU/US markets. Looking forward to Atte...
5/5/2026, 9:48 AM
12
Read more on our forum
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.